Media Staff

Department of Public Affairs

Recent Blog Posts

Pictured: Jedd Wolchok
In the Clinic
Thursday, April 4, 2013

Early research led by investigators at Memorial Sloan-Kettering cautions against combining ipilimumab and vemurafenib for the treatment of metastatic melanoma.

Pictured: Paul Sabbatini
Q&A
Tuesday, April 2, 2013

In his new role as Deputy Physician-in-Chief for Clinical Research, Paul Sabbatini aims to streamline, accelerate, and expand Memorial Sloan-Kettering’s clinical research program.

Pictured: John Mulhall
Q&A
Friday, March 8, 2013

Dr. Mulhall, director of Memorial Sloan-Kettering’s Male Sexual and Reproductive Medicine Program, explains common concerns about male sexual health and offers advice for men and their partners.

Pictured: Charles Sawyers
Honor
Wednesday, February 20, 2013

Charles Sawyers, Chair of Memorial Sloan-Kettering’s Human Oncology and Pathogenesis Program, is a recipient of the inaugural $3 million prize for groundbreaking achievements in scientific research.

Pictured: James Fagin
In the Clinic
Thursday, February 14, 2013

Researchers have found that the investigational drug selumetinib shuts down the signaling of genetic mutations that prevent some patients’ thyroid cancer tumors from absorbing radioiodine, the most effective treatment for the disease.

Pictured: Mammogram
Q&A
Wednesday, January 30, 2013

A New York State law that went into effect this month requires radiologists to inform women if they have dense breasts. Dr. Lee answers questions about the concept of breast density and what women should know.

Pictured: Kenneth Yu
In the Clinic
Tuesday, January 29, 2013

New research suggests that analyzing genetic changes found in the bloodstream may help doctors predict which chemotherapy regimens will work for some patients.

Pictured: Charles Sawyers' Laboratory
In the Clinic
Monday, January 7, 2013

The American Society of Clinical Oncology’s notable research advances include the approval of a new drug for men with advanced prostate cancer that was developed and studied by Memorial Sloan-Kettering researchers.

Pictured: Michel Sadelain & Jedd Wolchok
Announcement
Wednesday, December 12, 2012

Physician-scientists Michel Sadelain and Jedd Wolchok have been appointed to a new research team dedicated to investigating ways to harness the immune system to fight cancer.

Pictured: Ethel Law & Elizabeth Grahn
Announcement
Monday, December 10, 2012

Memorial Sloan-Kettering advanced practice nurses Elizabeth Grahn and Ethel Law have been recognized for their extraordinary achievements in education and research.

Pictured: Charles Sawyers
Announcement
Saturday, December 8, 2012

Charles Sawyers, Chair of Memorial Sloan-Kettering’s Human Oncology and Pathogenesis Program, is widely recognized as someone who is revolutionizing the molecular treatment of cancer.

Research
Pictured: Michael Zelefsky
In the Clinic
Friday, November 30, 2012

Study signals hope for maintaining sexual function in men undergoing radiation treatment for prostate cancer.

Q&A
Wednesday, November 21, 2012

Cancer patients use more blood and platelets than patients with any other illness. Memorial Sloan-Kettering is always in need of blood donations – especially during the holiday season.

Pictured: Zuckerman Research Center
Announcement
Wednesday, October 17, 2012

Memorial Sloan-Kettering’s new research complex contains more than 100 laboratories, nearly doubling the space we dedicate to research to better understand and treat cancer.

Research
Pictured: Robin Roberts
In the News
Thursday, October 11, 2012

Good Morning America co-host Robin Roberts recently said good-bye to her inpatient treatment team at Memorial Sloan-Kettering after undergoing a stem cell transplant to treat myelodysplastic syndrome.